The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis
Abstract
Background The reported prevalence of small intestinal bacterial overgrowth (SIBO) among individuals with irritable bowel syndrome (IBS) is highly variable. The aim of the study is to estimate the prevalence and identify predictors of SIBO in IBS.Methods PubMed, Cochrane Library, and EMBASE through July 2017 were searched to identify studies evaluating the prevalence of SIBO in IBS. The pooled prevalence of SIBO among individuals with IBS and the pooled odds ratio (OR) of SIBO among those with IBS compared with healthy controls were calculated. Predictors of SIBO among IBS patients were also evaluated.Results Fifty studies (8398 IBS, 1432 controls) met the inclusion criteria. Overall pooled prevalence of SIBO in IBS was 38% (95% CI 32-44) and was higher among individuals with IBS (OR 4.7, 95% CI 3.1-7.2) compared with controls. The pooled prevalence of SIBO in IBS was higher in studies diagnosed by breath tests (40%, 95% CI 33-46) compared with cultures (19%, 95% CI 8-30). Among those with IBS, female gender (OR 1.5, 95% CI 1.0-2.1), older age (standard mean difference 3.1 years, 95% CI 0.9-5.4), and IBS-diarrhea (OR 1.7, 95% CI 1.3-2.3) compared with other IBS subtypes increased the odds of SIBO; proton pump inhibitor (PPI) use (OR 1.1, 95% CI 0.7-1.7) was not associated with SIBO.Conclusions More than one-third of IBS patients tested positive for SIBO, and the odds of SIBO in IBS were increased by nearly fivefold. The prevalence of SIBO varied according to the diagnostic modality performed. Female gender, older age, and IBS-diarrhea, but not PPI use, were associated with SIBO among individuals with IBS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Low fermentable oligosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diets, a mainstay of IBS management, and small intestinal bacterial overgrowth (SIBO), a complication of IBS, are both related to alterations in the microbiota.”
From Association Between Sex Hormone Levels and Gut Microbiota Composition and Diversity—A Systematic Review (2022) · cites this paper as [47]
Citations
Cites
(2014) · Medical Entomology and Zoology · Cited by 17,633
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155 · cited 1×
“affects more than a tenth of the general population [1, 2].”
(2012) · Hepatogastroenterology · doi:10.5754/hge12281 · Cited by 2,097
Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03368.x · Cited by 780
Biesiekierski, J. R., Newnham, E. D., Irving, P. M., Barrett, J. S., Haines, M., Doecke, J. D., Shepherd, S. J., Muir, J. G., & Gibson, P. R. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.487 · Cited by 717
Small intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620 · cited 1×
“Although the gold standard for diagnosing SIBO is considered to be small intestinal fluid aspiration to quantify bacterial culture [9], other less-invasive Electronic supplementary material The online version of this article (https://doi.”
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
Posserud, I., Stotzer, P.-O., Björnsson, E. S., Abrahamsson, H., & Simrén, M. (2007) · Gut · doi:10.1136/gut.2006.108712 · Cited by 499 · cited 3×
“The reported prevalence of SIBO in the IBS population is highly variable, ranging from 4 to 84%, which may be related to the testing methods performed to diagnose SIBO [7, 11].”
Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis
Lo, W., & Chan, W. W. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.011 · Cited by 353 · cited 1×
“However, the risk of SIBO specifically among individuals with IBS is unclear [19, 76].”
Ford, A. C., Spiegel, B. M. R., Talley, N. J., & Moayyedi, P. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.06.031 · Cited by 351 · cited 2×
“Due to the potential inaccuracy of small studies, we excluded studies with less than eighty individuals as the previous meta-analysis [6].”
Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy
Lombardo, L., Foti, M., Ruggia, O., & Chiecchio, A. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.12.022 · Cited by 350 · cited 1×
“Four case–control studies containing 308 healthy controls and 661 IBS patients who had not used PPI prior to testing for SIBO were identified [23, 35, 37, 39].”
Research works printed but not linked: 4
- Philip A, Joseph V, Mukunda M, et al. Prevalence of small intestinal bacterial overgrowth in patients with irritable bowel syndrome using lactulose hydrogen breath test. Indian J Gastroenterol. 2013;32(1):A31.
- Qing Y. Relationship between the irritable bowel syndrome and small intestinal bacterial. J Gastroenterol Hepatol. 2013;28:375.
- Man F, Bustos Fernandez L, Bolino C. Prevalence of abnormal hydrogen excretion in non constipated irritable bowel syndrome patients. J Gastroenterol Hepatol. 2013;28:124.
- McCallum R, Schultz C, Sostarich S. Evaluating the role of small intestinal bacterial overgrowth (SIBO) in diarrhea predominant irritable bowel syndrome (IBS-D) patients utilizing the glucose breath test (GBT). Gastroenterology. 2005;128(4):A460.
Cited by
Kastl, A. J., Terry, N. A., Wu, G. D., & Albenberg, L. G. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.07.006 · Cited by 358
Advancing human gut microbiota research by considering gut transit time
Procházková, N., Falony, G., Dragsted, L. O., Licht, T. R., Raes, J., & Roager, H. M. (2023) · Gut · doi:10.1136/gutjnl-2022-328166 · Cited by 308
“183 SIBO is prevalent among patients with IBS, 184 a condition characterised by abdominal pain or discomfort and associated with changes in bowel habits affecting more than a tenth of the general population.”
BackgroundWang, L., Alammar, N., Singh, R., Nanavati, J., Song, Y., Chaudhary, R., & Mullin, G. E. (2020) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.05.015 · Cited by 209
Shah, A., Talley, N. J., Jones, M., Kendall, B. J., Koloski, N., Walker, M. M., Morrison, M., & Holtmann, G. J. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000504 · Cited by 200
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome—An Update
Takakura, W., & Pimentel, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00664 · Cited by 148
“A positive H2 breath test is diagnostic of SIBO, which has been associated with diarrheapredominant IBS (IBS-D) and IBS with mixed bowel habits (IBSM) (10).”
Background
Metadata
- Authors
- Chen, B., Kim, J. J.-W., Zhang, Y., Du, L., & Dai, N.
- Affiliations
- Sir Run Run Shaw Hospital (CN)
- Loma Linda University Medical Center (US)
- Corresponding author
- Dai, Ning
- Venue
- Journal of Gastroenterology
- Published
- 2018-05-14
- Volume
- 53
- Issue
- 7
- Pages
- 807-818
- ISSN
- 0944-1174 (ISSN-L)
- 1435-5922
- OpenAlex
- W2802465698
- Cited by
- 117
- References
- 75
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 21 · 2023: 14 · 2022: 16 · 2021: 13 · 2020: 18 · 2019: 16 · 2018: 4
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81670487)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Keywords
- small intestinal bacterial overgrowth, irritable bowel syndrome, prevalence, risk factors, breath test, culture diagnosis, proton pump inhibitors, female sex, old age
- MeSH terms
- Adult, Age Factors, Bacterial Infections, Breath Tests, Diarrhea, Female, Humans, Intestine, Small, Male, Middle Aged, Sex Factors, Prevalence, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1007/s00535-018-1476-9
- The paper
- Chen, B., Kim, J. J.-W., Zhang, Y., Du, L., & Dai, N. (2018). Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis. Journal of Gastroenterology. https://doi.org/10.1007/s00535-018-1476-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.